6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
Cellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:851c6bd2a26549a4b642403b49029a4d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:851c6bd2a26549a4b642403b49029a4d2021-11-15T06:05:32Z6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function10.7554/eLife.674762050-084Xe67476https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d2021-10-01T00:00:00Zhttps://elifesciences.org/articles/67476https://doaj.org/toc/2050-084XCellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate pathway (PPP) or be used in glycolysis. Here, we showed that blocking 6-phosphogluconate dehydrogenase (6PGD) in the oxidative PPP resulted in substantial reduction of Tregs suppressive function and shifts toward Th1, Th2, and Th17 phenotypes which led to the development of fetal inflammatory disorder in mice model. These in turn improved anti-tumor responses and worsened the outcomes of colitis model. Metabolically, 6PGD blocked Tregs showed improved glycolysis and enhanced non-oxidative PPP to support nucleotide biosynthesis. These results uncover critical role of 6PGD in modulating Tregs plasticity and function, which qualifies it as a novel metabolic checkpoint for immunotherapy applications.Saeed DaneshmandiTeresa CasselRichard M HigashiTeresa W-M FanPankaj SetheLife Sciences Publications Ltdarticleregulatory T cellmetabolism6PGDimmunoregulationglucosepentose phosphate pathwayMedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
regulatory T cell metabolism 6PGD immunoregulation glucose pentose phosphate pathway Medicine R Science Q Biology (General) QH301-705.5 |
spellingShingle |
regulatory T cell metabolism 6PGD immunoregulation glucose pentose phosphate pathway Medicine R Science Q Biology (General) QH301-705.5 Saeed Daneshmandi Teresa Cassel Richard M Higashi Teresa W-M Fan Pankaj Seth 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
description |
Cellular metabolism has key roles in T cells differentiation and function. CD4+ T helper-1 (Th1), Th2, and Th17 subsets are highly glycolytic while regulatory T cells (Tregs) use glucose during expansion but rely on fatty acid oxidation for function. Upon uptake, glucose can enter pentose phosphate pathway (PPP) or be used in glycolysis. Here, we showed that blocking 6-phosphogluconate dehydrogenase (6PGD) in the oxidative PPP resulted in substantial reduction of Tregs suppressive function and shifts toward Th1, Th2, and Th17 phenotypes which led to the development of fetal inflammatory disorder in mice model. These in turn improved anti-tumor responses and worsened the outcomes of colitis model. Metabolically, 6PGD blocked Tregs showed improved glycolysis and enhanced non-oxidative PPP to support nucleotide biosynthesis. These results uncover critical role of 6PGD in modulating Tregs plasticity and function, which qualifies it as a novel metabolic checkpoint for immunotherapy applications. |
format |
article |
author |
Saeed Daneshmandi Teresa Cassel Richard M Higashi Teresa W-M Fan Pankaj Seth |
author_facet |
Saeed Daneshmandi Teresa Cassel Richard M Higashi Teresa W-M Fan Pankaj Seth |
author_sort |
Saeed Daneshmandi |
title |
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
title_short |
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
title_full |
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
title_fullStr |
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
title_full_unstemmed |
6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function |
title_sort |
6-phosphogluconate dehydrogenase (6pgd), a key checkpoint in reprogramming of regulatory t cells metabolism and function |
publisher |
eLife Sciences Publications Ltd |
publishDate |
2021 |
url |
https://doaj.org/article/851c6bd2a26549a4b642403b49029a4d |
work_keys_str_mv |
AT saeeddaneshmandi 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction AT teresacassel 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction AT richardmhigashi 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction AT teresawmfan 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction AT pankajseth 6phosphogluconatedehydrogenase6pgdakeycheckpointinreprogrammingofregulatorytcellsmetabolismandfunction |
_version_ |
1718428563422576640 |